30.06.2022 03:50

Melatonin Market size to grow by USD 1.49 Bn | Evolving Opportunities with Aspen Pharmacare Holdings Ltd. and B Joshi Agrochem Pharma | Technavio

Folgen
Werbung

NEW YORK, June 29, 2022 /PRNewswire/ -- The "Melatonin Market by Product and Geography - Forecast and Analysis 2022-2026" report by Technavio expects the market to observe an incremental growth of USD 1.49 billion between 2021 and 2026, expanding at a CAGR of 14.67% during the forecast period. The report identifies the market to observe maximum growth in North America. The increasing prevalence of sleeping disorders among people is generating high demand for melatonin in the region.

Technavio has announced its latest market research report titled Melatonin Market by Product and Geography - Forecast and Analysis 2022-2026

Read Our Report Sample for highlights on the market size, growth momentum, regional growth opportunities, and much more.

Market Dynamics

The market is driven by the increase in human life expectancy and the number of working hours. Advances in medicine are helping people to live longer. This is resulting in the availability of a larger workforce. The growing work pressure and busy work schedules are forcing people to adopt unhealthy eating habits and give less time to exercise and take part in fitness activities. All these factors have led to a rise in stress and anxiety levels among people. All these factors are increasing the demand for melatonin to relieve stress, thereby driving the growth of the market.

In addition, the rise in the geriatric population is anticipated to boost the growth of the melatonin market. However, stringent rules and regulations on the use of melatonin will hamper the growth of the market.

Major Vendors in the Melatonin Market:

The global melatonin market is concentrated in nature due to the presence of few vendors. The vendors in the market are focusing on the development of cost-effective products to gain a competitive edge. During the forecast period, the competition in the market is expected to intensify owing to innovations and product launches.

Technavio identifies the following as dominant players in the market.

  • Aspen Pharmacare Holdings Ltd.
  • B Joshi Agrochem Pharma
  • Biotics Research Corp.
  • BYHEALTH Co. Ltd.
  • Church and Dwight Co. Inc.
  • Harbin Pharmaceutical Group Co. Ltd.
  • Jamieson Wellness Inc.
  • Natrol LLC
  • Nestle SA
  • NOW Health Group Inc.
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.

Gain more insights into the vendor landscape and other factors influencing the growth of the market. View Report Sample Now

Segmentation Analysis

Melatonin Market Product Outlook (Revenue, USD Billion, 2021-2026)

  • Pharmaceutical grade melatonin - size and forecast 2021-2026
  • Food grade melatonin - size and forecast 2021-2026

The demand for pharmaceutical-grade melatonin will be significant during the forecast period. The increasing use of melatonin in treating sleep disorders due to its sedating and calming effect is driving the growth of the segment. Also, the wide availability of melatonin in the form of capsules, tablets, liquid, balms, roll-ons, vaping products, gummies, and others is contributing to the growth of the segment.

Melatonin Market Geography Outlook (Revenue, USD Billion, 2021-2026)

  • North America - size and forecast 2021-2026
  • Europe - size and forecast 2021-2026
  • APAC - size and forecast 2021-2026
  • South America - size and forecast 2021-2026
  • The Middle East and Africa - size and forecast 2021-2026

The North American region will dominate the market growth through the forecast period. The region has a large pool of health-conscious people and patients that suffer from sleep disorders. In addition, factors such as rising standards of living of people, an increase in disposable incomes, the growing awareness about sophisticated self-care systems, and the increase in the number of healthcare facilities are driving the growth of the regional market.

Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Read the Sample Report Now

Related Reports:

Melatonin Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 14.67%

Market growth 2022-2026

USD 1.49 billion

Market structure

Concentrated

YoY growth (%)

10.4

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 35%

Key consumer countries

US, Canada, China, Japan, and Germany

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Aspen Pharmacare Holdings Ltd., B Joshi Agrochem Pharma, Biotics Research Corp., BYHEALTH Co. Ltd., Church and Dwight Co. Inc., Harbin Pharmaceutical Group Co. Ltd., Jamieson Wellness Inc., Natrol LLC, Nestle SA, NOW Health Group Inc., Otsuka Holdings Co. Ltd., and Pfizer Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents:

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
    • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
    • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition
    • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
    • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
    • Exhibit 26: Chart on Comparison by Product
    • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Pharmaceutical grade melatonin - Market size and forecast 2021-2026
    • Exhibit 28: Chart on Pharmaceutical grade melatonin - Market size and forecast 2021-2026 ($ million)
    • Exhibit 29: Data Table on Pharmaceutical grade melatonin - Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Chart on Pharmaceutical grade melatonin - Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Pharmaceutical grade melatonin - Year-over-year growth 2021-2026 (%)
  • 5.4 Food grade melatonin - Market size and forecast 2021-2026
    • Exhibit 32: Chart on Food grade melatonin - Market size and forecast 2021-2026 ($ million)
    • Exhibit 33: Data Table on Food grade melatonin - Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Chart on Food grade melatonin - Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Food grade melatonin - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
    • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
    • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
    • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison
    • Exhibit 40: Chart on Geographic comparison
    • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
    • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
    • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
    • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
    • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
    • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 APAC - Market size and forecast 2021-2026
    • Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
  • 7.6 South America - Market size and forecast 2021-2026
    • Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
  • 7.7 Middle East and Africa - Market size and forecast 2021-2026
    • Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
  • 7.8 US - Market size and forecast 2021-2026
    • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
    • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
    • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
    • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
    • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
    • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
    • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
    • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
    • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Japan - Market size and forecast 2021-2026
    • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
    • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
    • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
    • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity by geography
    • Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
    • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
    • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
    • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
    • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
    • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
    • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Biotics Research Corp.
    • Exhibit 89: Biotics Research Corp. - Overview
    • Exhibit 90: Biotics Research Corp. - Product / Service
    • Exhibit 91: Biotics Research Corp. - Key offerings
  • 10.4 BYHEALTH Co. Ltd.
    • Exhibit 92: BYHEALTH Co. Ltd. - Overview
    • Exhibit 93: BYHEALTH Co. Ltd. - Product / Service
    • Exhibit 94: BYHEALTH Co. Ltd. - Key offerings
  • 10.5 Church and Dwight Co. Inc.
    • Exhibit 95: Church and Dwight Co. Inc. - Overview
    • Exhibit 96: Church and Dwight Co. Inc. - Business segments
    • Exhibit 97: Church and Dwight Co. Inc. - Key news
    • Exhibit 98: Church and Dwight Co. Inc. - Key offerings
    • Exhibit 99: Church and Dwight Co. Inc. - Segment focus
  • 10.6 Harbin Pharmaceutical Group Co. Ltd.
    • Exhibit 100: Harbin Pharmaceutical Group Co. Ltd. - Overview
    • Exhibit 101: Harbin Pharmaceutical Group Co. Ltd. - Product / Service
    • Exhibit 102: Harbin Pharmaceutical Group Co. Ltd. - Key offerings
  • 10.7 Jamieson Wellness Inc.
    • Exhibit 103: Jamieson Wellness Inc. - Overview
    • Exhibit 104: Jamieson Wellness Inc. - Business segments
    • Exhibit 105: Jamieson Wellness Inc. - Key news
    • Exhibit 106: Jamieson Wellness Inc. - Key offerings
    • Exhibit 107: Jamieson Wellness Inc. - Segment focus
  • 10.8 Natrol LLC
    • Exhibit 108: Natrol LLC - Overview
    • Exhibit 109: Natrol LLC - Product / Service
    • Exhibit 110: Natrol LLC - Key offerings
  • 10.9 Nestle SA
    • Exhibit 111: Nestle SA - Overview
    • Exhibit 112: Nestle SA - Business segments
    • Exhibit 113: Nestle SA - Key news
    • Exhibit 114: Nestle SA - Key offerings
    • Exhibit 115: Nestle SA - Segment focus
  • 10.10 NOW Health Group Inc.
    • Exhibit 116: NOW Health Group Inc. - Overview
    • Exhibit 117: NOW Health Group Inc. - Product / Service
    • Exhibit 118: NOW Health Group Inc. - Key offerings
  • 10.11 Otsuka Holdings Co. Ltd.
    • Exhibit 119: Otsuka Holdings Co. Ltd. - Overview
    • Exhibit 120: Otsuka Holdings Co. Ltd. - Business segments
    • Exhibit 121: Otsuka Holdings Co. Ltd. - Key offerings
    • Exhibit 122: Otsuka Holdings Co. Ltd. - Segment focus
  • 10.12 Pfizer Inc.
    • Exhibit 123: Pfizer Inc. - Overview
    • Exhibit 124: Pfizer Inc. - Product / Service
    • Exhibit 125: Pfizer Inc. - Key news
    • Exhibit 126: Pfizer Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
    • Exhibit 127: Inclusions checklist
    • Exhibit 128: Exclusions checklist
  • 11.3 Currency conversion rates for US$
    • Exhibit 129: Currency conversion rates for US$
  • 11.4 Research methodology
    • Exhibit 130: Research methodology
    • Exhibit 131: Validation techniques employed for market sizing
    • Exhibit 132: Information sources
  • 11.5 List of abbreviations
    • Exhibit 133: List of abbreviations

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/melatonin-market-size-to-grow-by-usd-1-49-bn--evolving-opportunities-with-aspen-pharmacare-holdings-ltd-and-b-joshi-agrochem-pharma--technavio-301577266.html

SOURCE Technavio

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Rezessionssorgen schwinden: DAX schließt klar im Plus -- Dow Jones letztlich etwas höher -- Siemens Energy will Jahresziele erreichen -- Palantir enttäuscht -- BioNTech, Bayer, Lufthansa im Fokus

NVIDIA enttäuscht mit Umsatzausblick. AMC-Aktie kurzzeitig vom Handel ausgesetzt. Pfizer plant Milliardenübernahme. Givaudan-Aktie profitiert von Einstieg der Tetra-Pak-Familie. Porsche steigert Gewinn im ersten Halbjahr deutlich. Samsung will in Deutschland eine halbe Million Falt-Smartphones verkaufen. Hypoport steigert Gewinn deutlich. Kalifornische Fahrzeugbehörde reicht Klage gegen Tesla ein.

Umfrage

Worüber machen Sie sich derzeit die größeren Sorgen?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln